A2A agonist in combination with an anticholinergic agent for the treatment of obstructive Airway Diseases

摘要

1. A combination of inhalation of a selective adenosine A2a receptor agonist and an anticholinergic agent, with the proviso that the anticholinergic agent is not a tiotropium salt. 2. A combination according to claim 1, characterized in that The selective adenosine A2a receptor agonist is a compound generally or specifically disclosed in WO-A-00/23457, WO-A-00/77018, WO-A-01/27131, WO-A-01/27130, WO- A-01/60835, WO-A-02/00676 or WO-A-01/94368.